Additional policy changes can help change key factors that drive obesity.
Articles on Pharmaceuticals
Displaying 21 - 40 of 262 articles
The drug information sheets that the FDA requires companies to produce are living documents that get updated with new information.
As the generics market for a particular drug gets crowded, competition on price might be driving quality issues that could harm patients.
This recall affects America’s most prescribed drug. It’s the latest in a series of concerning manufacturing issues that have come to light over the past few years.
African countries are too dependent on importation of active pharmaceutical ingredients.
By extending their monopoly on a drug, companies prevent generics and other competitors from driving down prices. But increasing transparency can help prevent Big Pharma from gaming the patent system.
The little blue pill stars are using to calm their jitters.
Kratom, an herbal product, is a remedy to some and a risk to others.
The pharmacist will see you now. Will a proposal for pharmacists to work out of GP clinics really work? Here’s what we know so far.
The US is Australia’s biggest export market for pharmaceuticals. If the tariffs go ahead, manufacturing could suffer.
AI models can help us to repurpose existing medicines, cutting research costs and timescales.
Pharmaceutical companies have little incentive to sell drugs to countries that can’t afford them. But bargaining together can increase access to vital treatments worldwide.
What you should know about phthalates in softgel medications and supplements.
Precise and flexible 3D manufacturing techniques make it possible to individually tailor everything from prosthetics to drugs.
Boosting Australia’s ability to make pharmaceuticals sounds like a great way to ease medicine shortages. But there are simpler, cheaper options we could try first.
After May 1, the drug will cost a tiny fraction of its original price. But it can’t be taken at home.
Pharmaceutical pollution can significantly affect wild animal behaviour, including speeding up salmon migration.
The major parties say they won’t use the PBS as a bargaining chip in US tariff negotiations. They also need to resist pressure to slow down access to generic drugs.
Australia has escaped some of the highest tariff levels, but will still feel economic pain. There are three main ways we can respond.
The secret behind weird medicine names.
Top contributors
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Director and Taylor Family Chair, Centre for the Business & Economics of Health, The University of Queensland
-
Lecturer Pharmacy Practice, University of Sydney
-
Conjoint Clinical Associate Professor, Deakin University School of Medicine and Specialist Pain Medicine Physician, Deakin University
-
Pharmacist and PhD Candidate, University of Sydney
-
Professor of Bioethics, Macquarie University
-
Assistant Professor of Resource Economics, UMass Amherst
-
Professor of Trade Law and Taxation, Queensland University of Technology
-
Senior Research Manager, University of Sydney and Honorary Assistant Professor, Bond University
-
PhD Candidate, Swinburne University of Technology
-
Professor in Pharmaceutical Policy, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Senior Lecturer, Pharmacy, Aston University
-
Professor of Economics, Loughborough University